GlassScriptPhysician profile
Robert Craig Dabrow
NPI 1760442321
$1,000.47
in general payments reported to CMS, 2019-2025
18 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $110 · 2021: $206 · 2022: $148 · 2023: $62.62 · 2024: $140 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $209.28 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Phadia US INC. | $144.61 | 2019-2024 | Immunocap |
| Cranial Technologies, INC | $133.32 | 2019-2025 | Doc Band |
| Pfizer INC. | $90.58 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $59.86 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $54.53 | 2019-2021 | |
| Sanofi Pasteur INC. | $48.30 | 2019-2024 | |
| Tris Pharma INC | $47.71 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $38.88 | 2021 | |
| Merck Sharp & Dohme LLC | $34.02 | 2022-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Cipher Pharmaceuticals US LLC | $22.63 | 2025 | Spinosad, Natroba |
| Seqirus USA INC | $22.07 | 2025 | Flucelvax |
| Neurelis, INC. | $21.72 | 2021 | |
| Aytu Biopharma, INC. | $17.07 | 2025 | |
| Nestle Healthcare Nutrition INC. | $16.56 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.28 | 2021 | |
| Meridian Bioscience INC. | $12.32 | 2023 | |
| Supernus Pharmaceuticals, INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dabrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.